Charter Renewal of the Advisory Committee on Blood and Tissue Safety and Availability, 83894 [2024-24133]

Download as PDF 83894 Federal Register / Vol. 89, No. 202 / Friday, October 18, 2024 / Notices guidance-documents, or https:// www.regulations.gov. present government-issued identification prior to entry.’’ Dated: October 10, 2024. Eric Flamm, Acting Associate Commissioner for Policy. Amy P. McNulty, Deputy Director, Executive Secretariat. [FR Doc. 2024–24108 Filed 10–17–24; 8:45 am] BILLING CODE 4165–15–P [FR Doc. 2024–24165 Filed 10–17–24; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Charter Renewal of the Advisory Committee on Blood and Tissue Safety and Availability Health Resources and Services Administration Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: Meeting of the National Advisory Council on Migrant Health; Amended Notice of Meeting Health Resources and Services Administration (HRSA), Department of Health and Human Services. AGENCY: Notice; amended notice of meeting. ACTION: HRSA published a notice in the Federal Register of July 23, 2024, concerning a meeting of the National Advisory Council on Migrant Health on October 22, 2024, and October 23, 2024. The notice states the meeting will be held in-person and via webinar. However, due to the impact of recent hurricanes on council members, this meeting now will be held via webinar only on Zoom. SUMMARY: Liz Rhee, National Advisory Council on Migrant Health Designated Federal Official, Office of Policy and Program Development, Bureau of Primary Health Care, HRSA, 5600 Fishers Lane, Rockville, MD 20857; 301–443–1082 or hrsabphcoppdnacmh@hrsa.gov. FOR FURTHER INFORMATION CONTACT: SUPPLEMENTARY INFORMATION: khammond on DSKJM1Z7X2PROD with NOTICES Amended Notice of Meeting In the Federal Register Notice of July 23, 2024, FR Doc. 2024–16119, page 59744, column 1, section 2, paragraph 3, amend the sentences ‘‘This meeting will be held in-person and via webinar. The address of the meeting is 5600 Fishers Lane, Rockville, MD 20857’’ to read: ‘‘This meeting will be held via webinar only.’’ In paragraph 8, delete the following sentences: ‘‘Since this meeting occurs in a federal government building, attendees must go through a security check to enter the building. Non-U.S. citizen attendees must notify HRSA of their planned attendance at least 20 business days prior to the meeting to facilitate their entry into the building. All attendees are required to VerDate Sep<11>2014 16:48 Oct 17, 2024 Jkt 265001 The Department of Health and Human Services is hereby giving notice that the charter for the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) has been renewed. FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal Officer for the ACBTSA; Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services, Tower Building, 1101 Wootton Parkway, Rockville, MD 20852. Phone: (202) 795–7608. Email: ACBTSA@ hhs.gov. SUPPLEMENTARY INFORMATION: The ACBTSA is a non-discretionary federal advisory committee. The ACBTSA is authorized under 42 U.S.C. 217a, section 222 of the Public Health Service (PHS) Act, as amended. The Committee is governed by the provisions of the Federal Advisory Committee Act (FACA), Public Law 92–463, as amended (5 U.S.C. App), which sets forth standards for the formation and use of advisory committees. The ACBTSA advises, assists, consults with, and makes policy recommendations to the Secretary, through the Assistant Secretary for Health, regarding broad responsibilities related to the safety of blood, blood products, tissues, and organs. For solid organs and blood stem cells, the Committee’s work is limited to policy issues related to donor derived infectious disease complications of transplantation. To carry out its mission, the ACBTSA provides advice to the Secretary through the Assistant Secretary for Health on a range of policy issues which includes: (1) identification of public health issues through surveillance of blood and tissue safety issues with national biovigilance data tools; (2) identification of public SUMMARY: PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 health issues that affect availability of blood, blood products, and tissues; (3) broad public health, ethical, and legal issues related to the safety of blood, blood products, and tissues; (4) the impact of various economic factors (e.g., product cost and supply) on safety and availability of blood, blood products, and tissues; (5) risk communications related to blood transfusion and tissue transplantation; and (6) identification of infectious disease transmission issues for blood, organs, blood stem cells and tissues. On September 25, 2024, the Secretary approved for the ACBTSA charter to be renewed. Renewal of the Committee’s charter gives authorization for the Committee to continue to operate until October 9, 2026. A copy of the ACBTSA charter is available on the Committee’s website at https://www.hhs.gov/oidp/advisorycommittee/blood-tissue-safetyavailability/charter/. Dated: October 3, 2024. James J. Berger, DFO, Advisory Committee on Blood and Tissue Safety and Availability, Office of Infectious Disease and HIV/AIDS Policy. [FR Doc. 2024–24133 Filed 10–17–24; 8:45 am] BILLING CODE 4150–41–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Secretary’s Advisory Committee on Human Research Protections Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health. ACTION: Notice. AGENCY: Pursuant to section 10(a) of the Federal Advisory Committee Act, U.S.C. Appendix 2, notice is hereby given that the Secretary’s Advisory Committee on Human Research Protections (SACHRP) will hold a meeting that will be open to the public. Information about SACHRP, the full meeting agenda, and instructions for linking to public access will be posted on the SACHRP website at https:// www.hhs.gov/ohrp/sachrp-committee/ meetings/. DATES: The meeting will be held on Tuesday, October 22, 2024, from 11:00 a.m. until 4:30 p.m. (times are tentative and subject to change). The confirmed times and agenda will be posted on the SACHRP website as this information becomes available. ADDRESSES: This meeting will be held via webcast. Members of the public may SUMMARY: E:\FR\FM\18OCN1.SGM 18OCN1

Agencies

[Federal Register Volume 89, Number 202 (Friday, October 18, 2024)]
[Notices]
[Page 83894]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24133]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Charter Renewal of the Advisory Committee on Blood and Tissue 
Safety and Availability

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services is hereby giving 
notice that the charter for the Advisory Committee on Blood and Tissue 
Safety and Availability (ACBTSA) has been renewed.

FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal 
Officer for the ACBTSA; Office of Infectious Disease and HIV/AIDS 
Policy, Office of the Assistant Secretary for Health, Department of 
Health and Human Services, Tower Building, 1101 Wootton Parkway, 
Rockville, MD 20852. Phone: (202) 795-7608. Email: [email protected].

SUPPLEMENTARY INFORMATION: The ACBTSA is a non-discretionary federal 
advisory committee. The ACBTSA is authorized under 42 U.S.C. 217a, 
section 222 of the Public Health Service (PHS) Act, as amended. The 
Committee is governed by the provisions of the Federal Advisory 
Committee Act (FACA), Public Law 92-463, as amended (5 U.S.C. App), 
which sets forth standards for the formation and use of advisory 
committees. The ACBTSA advises, assists, consults with, and makes 
policy recommendations to the Secretary, through the Assistant 
Secretary for Health, regarding broad responsibilities related to the 
safety of blood, blood products, tissues, and organs. For solid organs 
and blood stem cells, the Committee's work is limited to policy issues 
related to donor derived infectious disease complications of 
transplantation.
    To carry out its mission, the ACBTSA provides advice to the 
Secretary through the Assistant Secretary for Health on a range of 
policy issues which includes: (1) identification of public health 
issues through surveillance of blood and tissue safety issues with 
national biovigilance data tools; (2) identification of public health 
issues that affect availability of blood, blood products, and tissues; 
(3) broad public health, ethical, and legal issues related to the 
safety of blood, blood products, and tissues; (4) the impact of various 
economic factors (e.g., product cost and supply) on safety and 
availability of blood, blood products, and tissues; (5) risk 
communications related to blood transfusion and tissue transplantation; 
and (6) identification of infectious disease transmission issues for 
blood, organs, blood stem cells and tissues.
    On September 25, 2024, the Secretary approved for the ACBTSA 
charter to be renewed. Renewal of the Committee's charter gives 
authorization for the Committee to continue to operate until October 9, 
2026.
    A copy of the ACBTSA charter is available on the Committee's 
website at https://www.hhs.gov/oidp/advisory-committee/blood-tissue-safety-availability/charter/.

    Dated: October 3, 2024.
James J. Berger,
DFO, Advisory Committee on Blood and Tissue Safety and Availability, 
Office of Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2024-24133 Filed 10-17-24; 8:45 am]
BILLING CODE 4150-41-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.